Table of Content

1. Preface
1.1. Report Scope
1.2. Market Segmentation
1.3. Research Highlights

2. Assumptions and Research Methodology
2.1. Assumptions
2.2. Research Methodology

3. Executive Summary

4. Market Overview
4.1. Product Type Overview
4.2. Key Industry Events
4.3. Market Opportunity Map

5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.3. Restraints
5.4. Opportunity Analysis
5.5. Opportunities
5.6. Trends
5.7. Porter’s Five Forces Analysis
5.8. Value Chain Snapshot

6. Global Pulmonary Drugs Market Analysis, by Product Type
6.1. Key Findings
6.2. Introduction
6.3. Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type
6.4. Global Pulmonary Drug Delivery Devices Market Forecast, by Product Type
6.4.1. Global Dry Powder Inhalers (DPIs) Market Revenue (US$ Mn) and Volume (Million Units), 2017–2031
6.4.2. Global Metered Dose Inhalers (MDIs) Market Revenue (US$ Mn) and Volume (Million Units), 2017–2031
6.4.3. Global Nebulizers Market Revenue (US$ Mn) and Volume (Million Units), 2017–2031
6.5. Global Pulmonary Drugs Market Attractiveness Analysis, by Product Type
6.6. Key Trends

7. Global Pulmonary Drug Delivery Devices Market Analysis, by Application
7.1. Key Findings
7.2. Introduction
7.3. Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2017 and 2031
7.4. Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and volume (Million Units) Forecast, by Application, 2017–2031
7.4.1. Global Asthma Market Revenue (US$ Mn) and volume (Million Units), 2017–2031
7.4.2. Global COPD Market Revenue (US$ Mn) and volume (Million Units), 2017–2031
7.4.3. Global Cystic Fibrosis Market Revenue (US$ Mn) and volume (Million Units), 2017–2031
7.4.4. Global Other Applications Market Revenue (US$ Mn) and volume (Million Units), 2017–2031
7.4.5. Global Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application
7.5. Key Trends

8. Pulmonary Drug Delivery Devices Market Analysis, by Distribution Channel
8.1. Key Findings
8.2. Introduction
8.3. Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2017 and 2031
8.4. Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2017–2031
8.4.1. Global Retail Pharmacies Market Revenue (US$ Mn) and Volume (Million Units), 2017–2031
8.4.2. Global Hospital Pharmacies Market Revenue (US$ Mn) and Volume (Million Units), 2017–2031
8.4.3. Global E-commerce Market Revenue (US$ Mn) and Volume (Million Units), 2017–2031
8.5. Global Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel

9. Pulmonary Drug Delivery Devices Market Analysis, by Region
9.1. Global Scenario
9.2. Global Pulmonary Drug Delivery Devices Market Value Share Analysis By Region, 2017 and 2031
9.3. Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Region, 2017–2031
9.4. Global Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Region

10. North America Pulmonary Drug Delivery Devices Market Analysis
10.1. Key Findings
10.2. North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, 2017–2031
10.3. North America Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2017–2031
10.4. North America Market Attractiveness Analysis, by Country, 2022–2031
10.5. North America Market Value Share Analysis, by Product Type, 2017 and 2031
10.6. North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2017–2031
10.7. North America Market Value Share Analysis, by Application, 2017 and 2031
10.8. North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2017–2031
10.9. North America Market Revenue Share Analysis, by Distribution Channel, 2017 and 2031
10.10. North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2017–2031
10.11. North America Market Value Share Analysis, by Country, 2017 and 2031
10.12. North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Country, 2017–2031
10.13. North America Market Attractiveness Analysis, by Product Type, 2022–2031
10.14. North America Market Attractiveness Analysis, by Application, 2022–2031
10.15. North America Market Attractiveness Analysis, by Distribution Channel, 2022–2031

11. Europe Pulmonary Drug Delivery Devices Market Analysis
11.1. Key Findings
11.2. Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, 2017–2031
11.3. Europe Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2017–2031
11.4. Europe Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
11.5. Europe Market Value Share Analysis, by Product Type, 2017 and 2031
11.6. Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2017–2031
11.7. Europe Market Value Share Analysis, by Application, 2017 and 2031
11.8. Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2017–2031
11.9. Europe Market Revenue Share Analysis, by Distribution Channel, 2017 and 2031
11.10. Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2017–2031
11.11. Europe Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
11.12. Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Country, 2017–2031
11.13. Europe Market Attractiveness Analysis, by Product Type, 2022–2031
11.14. Europe Market Attractiveness Analysis, by Application, 2022–2031
11.15. Europe Market Attractiveness Analysis, by Distribution Channel, 2022–2031

12. Asia Pacific Pulmonary Drug Delivery Devices Market Analysis
12.1. Key Findings
12.2. Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, 2017–2031
12.3. Asia Pacific Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2017–2031
12.4. Asia Pacific Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
12.5. Asia Pacific Market Value Share Analysis, by Product Type, 2017 and 2031
12.6. Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2017–2031
12.7. Asia Pacific Market Value Share Analysis, by Application, 2017 and 2031
12.8. Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2017–2031
12.9. Asia Pacific Market Revenue Share Analysis, by Distribution Channel, 2017 and 2031
12.10. Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2017–2031
12.11. Asia Pacific Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
12.12. Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Country, 2017–2031
12.13. Asia Pacific Market Attractiveness Analysis, by Product Type, 2022–2031
12.14. Asia Pacific Market Attractiveness Analysis, by Application, 2022–2031
12.15. Asia Pacific Market Attractiveness Analysis, by Distribution Channel, 2022–2031
13. Latin America Pulmonary Drug Delivery Devices Market Analysis
13.1. Key Findings
13.2. Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, 2017–2031
13.3. Latin America Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2017–2031
13.4. Latin America Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
13.5. Latin America Market Value Share Analysis, by Product Type, 2017 and 2031
13.6. Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2017–2031
13.7. Latin America Market Value Share Analysis, by Application, 2017 and 2031
13.8. Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2017–2031
13.9. Latin America Market Revenue Share Analysis, by Distribution Channel, 2017 and 2031
13.10. Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2017–2031
13.11. Latin America Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
13.12. Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Country, 2017–2031
13.13. Latin America Market Attractiveness Analysis, by Product Type, 2022–2031
13.14. Latin America Market Attractiveness Analysis, by Application, 2022–2031
13.15. Latin America Market Attractiveness Analysis, by Distribution Channel, 2022–2031

14. Middle East & Africa Pulmonary Drug Delivery Devices Market Analysis
14.1. Key Findings
14.2. Middle East & Africa Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, 2017–2031
14.3. Middle East & Africa Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2017–2031
14.4. Middle East & Africa Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
14.5. Middle East & Africa Market Value Share Analysis, by Product Type, 2017 and 2031
14.6. Middle East & Africa Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2017–2031
14.7. Middle East & Africa Market Value Share Analysis, by Application, 2017 and 2031
14.8. Middle East & Africa Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2017–2031
14.9. Middle East & Africa Market Revenue Share Analysis, by Distribution Channel, 2017 and 2031
14.10. Middle East & Africa Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2017–2031
14.11. Middle East & Africa Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
14.12. Middle East & Africa Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Country/Sub-region, 2017–2031
14.13. Middle East & Africa Market Attractiveness Analysis, by Product Type, 2022–2031
14.14. Middle East & Africa Market Attractiveness Analysis, by Application, 2022–2031
14.15. Middle East & Africa Market Attractiveness Analysis, by Distribution Channel, 2022–2031

15. Competition Landscape
15.1. Global Pulmonary Drugs Market Share Analysis, by Company, 2015
15.2. Competitive Dashboard
15.3. Pipeline Snapshot

16. Company Profiles
16.1. Boehringer Ingelheim GmbH
16.1.1. Company Overview
16.1.2. Business Overview
16.1.3. Financial Overview
16.1.4. SWOT Analysis
16.1.5. Strategic Overview
16.2. Novartis AG
16.2.1. Company Overview
16.2.2. Business Overview
16.2.3. Financial Overview
16.2.4. SWOT Analysis
16.2.5. Strategic Overview
16.3. GlaxoSmithKline plc
16.3.1. Company Overview
16.3.2. Business Overview
16.3.3. Financial Overview
16.3.4. SWOT Analysis
16.3.5. Strategic Overview
16.4. AstraZeneca plc
16.4.1. Company Overview
16.4.2. Business Overview
16.4.3. Financial Overview
16.4.4. SWOT Analysis
16.4.5. Strategic Overview
16.5. Teva Pharmaceutical Industries Ltd.
16.5.1. Company Overview
16.5.2. Business Overview
16.5.3. Financial Overview
16.5.4. SWOT Analysis
16.5.5. Strategic Overview
16.6. Merck & Co., Inc.
16.6.1. Company Overview
16.6.2. Business Overview
16.6.3. Financial Overview
16.6.4. SWOT Analysis
16.6.5. Strategic Overview
16.7. MannKind Corporation
16.7.1. Company Overview
16.7.2. Business Overview
16.7.3. Financial Overview
16.7.4. SWOT Analysis
16.7.5. Strategic Overview
16.8. F. Hoffmann-La Roche Ltd.
16.8.1. Company Overview
16.8.2. Business Overview
16.8.3. Financial Overview
16.8.4. SWOT Analysis
16.8.5. Strategic Overview
16.9. Bristol-Myers Squibb Company
16.9.1. Company Overview
16.9.2. Business Overview
16.9.3. Financial Overview
16.9.4. SWOT Analysis
16.9.5. Strategic Overview
16.10. Mylan N.V.
16.10.1. Company Overview
16.10.2. Business Overview
16.10.3. Financial Overview
16.10.4. SWOT Analysis
16.10.5. Strategic Overview
16.11. Omron Corporation
16.11.1. Company Overview
16.11.2. Business Overview
16.11.3. Financial Overview
16.11.4. SWOT Analysis
16.11.5. Strategic Overview
16.12. 3M Healthcare
16.12.1. Company Overview
16.12.2. Business Overview
16.12.3. Financial Overview
16.12.4. SWOT Analysis
16.12.5. Strategic Overview
16.13. Sunovion Pharmaceuticals, Inc.
16.13.1. Company Overview
16.13.2. Business Overview
16.13.3. Financial Overview
16.13.4. SWOT Analysis
16.13.5. Strategic Overview
16.14. Koninklijke Philips N.V.
16.14.1. Company Overview
16.14.2. Business Overview
16.14.3. Financial Overview
16.14.4. SWOT Analysis
16.14.5. Strategic Overview
16.15. Gerresheimer AG
16.15.1. Company Overview
16.15.2. Business Overview
16.15.3. Financial Overview
16.15.4. SWOT Analysis
16.15.5. Strategic Overview
16.16. Bespak
16.16.1. Company Overview
16.16.2. Business Overview
16.16.3. Financial Overview
16.16.4. SWOT Analysis
16.16.5. Strategic Overview
16.17. AptarGroup, Inc.
16.17.1. Company Overview
16.17.2. Business Overview
16.17.3. Financial Overview
16.17.4. SWOT Analysis
16.17.5. Strategic Overview
16.18. SHL Group
16.18.1. Company Overview
16.18.2. Business Overview
16.18.3. SWOT Analysis
16.18.4. Strategic Overview
16.19. Nypro Healthcare Inc. (Jabil Circuit Inc.)
16.19.1. Company Overview
16.19.2. Business Overview
16.19.3. Financial Overview
16.19.4. SWOT Analysis
16.19.5. Strategic Overview
16.20. Hovione
16.20.1. Company Overview
16.20.2. Business Overview
16.20.3. Financial Overview
16.20.4. SWOT Analysis
16.20.5. Strategic Overview
16.21. Chiesi Farmaceutici S.p.A.
16.21.1. Company Overview
16.21.2. Business Overview
16.21.3. Financial Overview
16.21.4. SWOT Analysis
16.21.5. Strategic Overview



List of Figures

List of Figures

Figure 01: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2017–2031

Figure 02: Global Dry Powder Inhalers Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2017-2031

Figure 03: Global Dry Powder Inhalers Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2017–2031

Figure 04: Global Metered Dose Inhalers Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2017–2031

Figure 05: Global Metered Dose Inhalers Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2017–2031

Figure 06: Global Nebulizers Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2017–2031

Figure 07: Global Nebulizers Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2017–2031

Figure 08: Global Single Dose Inhaler Market Volume and Y-o-Y Growth (%), 2017–2031

Figure 09: Global Multi Dose Inhaler Market Volume and Y-o-Y Growth (%), 2017-2031

Figure 10: Global Manually-actuated pressurized inhaler Market Volume and Y-o-Y Growth (%), 2017–2031

Figure 11: Global Breath-actuated pressurized inhaler Market Volume and Y-o-Y Growth (%), 2017-2031

Figure 12: Global Jet Nebulizers Market Volume and Y-o-Y Growth (%), 2017–2031

Figure 13: Global Ultrasonic Wave Nebulizers Market Volume and Y-o-Y Growth (%), 2017-2031

Figure 14: Global Vibrating Mesh Nebulizers Market Volume and Y-o-Y Growth (%), 2017-2031

Figure 15: Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type

Figure 16: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2017–2031

Figure 17: Global Asthma Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2017-2031

Figure 18: Asthma Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2017–2031

Figure 19: Global COPD Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2017-2031

Figure 20: COPD Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2017–2031

Figure 21: Global Cystic Fibrosis Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2017-2031

Figure 22: Cystic Fibrosis Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2017–2031

Figure 23: Global Others Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2017-2031

Figure 24: Others Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2017–2031

Figure 25: Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application

Figure 26: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2017–2031

Figure 27: Global Retail Pharmacies Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2017-2031

Figure 28: Retail Pharmacies Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2017–2031

Figure 29: Global Hospital Pharmacies Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2017-2031

Figure 31: Global E-commerce Market Revenue (US$ Mn) and Volume (Million Units) Growth Projections, 2017-2031

Figure 32: E-commerce Market Revenue (US$ Mn) and Volume Y-o-Y Growth Projections, 2017–2031

Figure 33: Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel

Figure 34: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Region, 2017–2031

Figure 35: Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Region

Figure 36: North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, 2017-2031

Figure 37: North America Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2017–2031

Figure 38: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Country

Figure 39: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product, 2017–2031

Figure 40: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2017–2031

Figure 41: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2017–2031

Figure 42: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country, 2017–2031

Figure 43: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product, 2022–2031

Figure 44: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application, 2022–2031

Figure 45: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 46: Europe Pulmonary drug delivery devices Market Size (US$ Mn) and Volume (Million Units) Forecast, 2017-2031

Figure 47: Europe Pulmonary drug delivery devices Market Size and Volume Y-o-Y Growth Projections, 2017–2031

Figure 48: Europe Pulmonary drug delivery devices Market Attractiveness Analysis, by Country/Sub-region

Figure 49: Europe Market Value Share Analysis, by Product Type, 2017–2031

Figure 50: Europe Market Value Share Analysis, by Application, 2017–2031

Figure 51: Europe Market Value Share Analysis, by Distribution Channel, 2017–2031

Figure 52: Europe Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2017–2031

Figure 53: Europe Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 54: Europe Market Attractiveness Analysis, by Application, 2022–2031

Figure 55: Europe Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 56: Asia Pacific Pulmonary drug delivery devices Market Size (US$ Mn) and Volume (Million Units) Forecast, 2017-2031

Figure 57: Asia Pacific Pulmonary drug delivery devices Market Y-o-Y Analysis, by Country

Figure 58: Asia Pacific Market Attractiveness Analysis, by Country/Sub-region , 2022–2031

Figure 59: Asia Pacific Market Value Share Analysis, by Product Type, 2017–2031

Figure 60: Asia Pacific Market Value Share Analysis, by Application, 2017–2031

Figure 61: Asia Pacific Market Value Share Analysis, by Distribution Channel, 2017–2031

Figure 62: Asia Pacific Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2017–2031

Figure 63: Asia Pacific Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 64: Asia Pacific Market Attractiveness Analysis, by Application, 2022–2031

Figure 65: Asia Pacific Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 66: Latin Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million units) Forecast, 2017-2031

Figure 67: Latin America Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2017–2031

Figure 68: Latin America Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 69: Latin America Market Value Share Analysis, by Product Type, 2017–2031

Figure 70: Latin America Market Value Share Analysis, by Application, 2017–2031

Figure 71: Latin America Market Value Share Analysis, by Distribution Channel, 2017–2031

Figure 72: Latin America Market Value Share Analysis, by Country/Sub-region, 2017–2031

Figure 73: Latin America Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 74: Latin America Market Attractiveness Analysis, by Application, 2022–2031

Figure 75: Latin America Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 76: MEA Market Size Value (US$ Mn) and Volume (Million Units) Forecast, 2017-2031

Figure 77: MEA Pulmonary Drug Delivery Devices Market Size and Volume Y-o-Y Growth Projections, 2017–2031

Figure 78: Middle East & Africa Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 79: Middle East & Africa Market Value Share Analysis, by Product Type, 2017–2031

Figure 80: Middle East & Africa Market Value Share Analysis, by Application, 2017–2031

Figure 81: Middle East & Africa Market Value Share Analysis, by Distribution Channel, 2017–2031

Figure 82: Middle East & Africa Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2017–2031

Figure 83: Middle East & Africa Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 84: Middle East & Africa Market Attractiveness Analysis, by Application, 2022–2031

Figure 85: Middle East & Africa Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 86: Global Pulmonary Drug Delivery Devices Market Share Analysis, by Company, 2021

List of Tables

List of Tables

Table 01: Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Product Type, 2017–2031

Table 02: Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler), 2017–2031

Table 03: Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler), 2017–2031

Table 04: Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Nebulizer), 2017–2031

Table 05: Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2017–2031

Table 06: Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2017-2031

Table 07: Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (No. of Units) Forecast, by Region, 2017–2031

Table 08: North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2017–2031

Table 09: North America Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Dry Powder Inhalers (Product) 2017–2031

Table 10: North America Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Metered Dose Inhalers (Product) 2017–2031

Table 11: North America Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Nebulizers (Product) 2017–2031

Table 12: North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2017–2031

Table 13: North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel 2017–2031

Table 14: North America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Country, 2017–2031

Table 15: Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2017–2031

Table 16: Europe Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler) 2017–2031

Table 17: Europe Pulmonary Drug Delivery Devices Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler) 2017–2031

Table 18: Europe Pulmonary Drug Delivery Devices and Volume (Million Units) Forecast, by Product Type, (Nebulizer) 2017–2031

Table 19: Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2017–2031

Table 20: Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2017–2031

Table 21: Europe Pulmonary Drug Delivery Devices Market Size (US$ Mn) ) and Volume (Million Units) Forecast, by Country/Sub-region, 2017–2031

Table 22: Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2017–2031

Table 23: Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler) 2017–2031

Table 24: Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler) 2017–2031

Table 25: Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, (Nebulizer) 2017–2031

Table 26: Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2017–2031

Table 27: Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2017–2031

Table 28: Asia Pacific Pulmonary Drug Delivery Devices Market Size (US$ Mn) ) and Volume (Million Units) Forecast, by Country/Sub-region, 2017–2031

Table 29: Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2017–2031

Table 30: Latin America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler) 2017–2031

Table 31: Latin America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler) 2017–2031

Table 32: Latin America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Nebulizer) 2017–2031

Table 33: Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Application, 2017–2031

Table 34: Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2017–2031

Table 35: Latin America Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Country/Sub-region, 2017–2031

Table 36: Middle East & Africa Pulmonary Drug Delivery Devices Market Size Value (US$ Mn) and Volume (Million Units) Forecast, by Product Type, 2017–2031

Table 37: Middle East & Africa Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Dry Powder Inhaler) 2017–2031

Table 38: Middle East & Africa Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Metered Dose Inhaler) 2017–2031

Table 39: Middle East & Africa Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, (Nebulizer) 2017–2031

Table 40: Middle East & Africa Pulmonary Drug Delivery Devices Market Size Value (US$ Mn) and Volume (Million Units) Forecast, by Application, 2017–2031

Table 41: Middle East & Africa Pulmonary Drug Delivery Devices Market Size Value (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2017–2031

Table 42: Middle East & Africa Pulmonary Drug Delivery Devices Market Size (US$ Mn) ) and Volume (Million Units) Forecast, by Country/Sub-region, 2017–2031